Arkolith/Insider Trading/PRAX/Form 4

DeSimone Jill

DirectorPraxis Precision Medicines, Inc. (PRAX) · full profile →Form 4 · filed Jun 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.6M
Net Open-Market Flow
-$3.6M
Transactions
16
14 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 24, 2026Option exercise(M)9K$44.25$379K11K
Jun 24, 2026Option exercise(M)3K$147.30$447K14K
Jun 24, 2026Sell(S)10$301.44$3K14K
Jun 24, 2026Sell(S)120$303.13$36K14K
Jun 24, 2026Sell(S)320$305.31$98K13K
Jun 24, 2026Sell(S)683$306.77$210K13K
Jun 24, 2026Sell(S)1K$308.24$382K12K
Jun 24, 2026Sell(S)999$309.38$309K11K
Jun 24, 2026Sell(S)2K$310.89$544K9K
Jun 24, 2026Sell(S)3K$311.91$890K6K
Jun 24, 2026Sell(S)1K$312.83$314K5K
Jun 24, 2026Sell(S)504$313.66$158K4K
Jun 24, 2026Sell(S)1K$314.90$403K3K
Jun 24, 2026Sell(S)837$315.70$264K2K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 24, 2026Option exercise(M)9K—$00
Jun 24, 2026Option exercise(M)3K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001930479-26-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML